Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus

Journal of Pharmaceutical Sciences

Volumn 87, Issue 9, 1998, Pages 1077-1080

  Newman, Robert A ^a   Chen, Wei ^a   Madden, Timothy L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CALANOLIDE A; DIHYDROCALANOLIDE B; NSC 678323; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0031716318     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980122d     Document Type: Article

References (15)

1. Lambert, J. S.; Seidlin, M.; Reichman, R. C.; Plank, C. S.; Laverty, M.; Morse, G. D.; Knupp, C.; McLaren, C.; Pettinelli, C.; Valentine, F. T.; Dolin, R. 2′,3′-dideoxyinosine (ddI) in patients with acquired immunodeficiency syndrome or AIDS-related complex. N. Eng. J. Med. 1990, 322, 1333-1340.
2. Cooley, T. P.; Kunches, L. M.; Saunders: C. A.; Ritter, J. K.; Perkins, C. J.; McLaren, C.; McCaffrey, R. P.; Liebman, H. A. Once daily administration of 2′,3′-dideoxyinosine (ddI) in patients with acquired immunodeficiency syndrome or AIDS-related comlex. Results of a Phase I trial. N. Engl. J. Med. 1990, 322, 1340-1345.
3. Larder, B. A.; Darby, G.; Richman, D. D. HIV with reduced sensitivity to zidovudine (AZT) isoltaed during prolonged therapy. Science 1989, 243, 1731-1734.
4. Richman, D. D. HIV drug resistance. AIDS Res. Hum. Retroviruses 1992, 8, 1065-1071.
5. Larder, B. A. Interactions with drug resistant mutations in human immunodeficiency virus type 1 reverse transcriptase. J. Gen. Virol. 1994, 75, 951-957.
6. Mayers, D. L.; Japour, A. J.; Arduino, J. M.; Hammer, S. M.; Reichman, R.; Wagner, K. F.; Chung, R.; Lane, J.; Crumpacker, C. S.; McLeod, G. X.; Beckett, L. A.; Roberts, C. A.; Weislow, D.; Burks, D. D. Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. Antimicrob. Agents Chemother. 1994, 38, 307-314.
7. Flavin, M. T.; Rizzo, J. D.; Khilevich, A.; Kucherenko, A.; Sheinkman, A. K.; Vilaychack, V.; Lin, L.; Chen, W.; Greenwood, E. M.; Pengsuparp, T.; Pexxuto, J. M.; Highes, S. H.; Flavin, T. M.; Cibuslki, M.; Boulanger, W. A.; Shone, R. L.; Xu, Z. Q. Synthesis, chromatographic resolution, and antihuman immunodeficiency virus activity of (±)-calanolide A and its enantiomers. J. Med. Chem. 1996, 39, 1303-1313.
8. Threlkeld, S. C.; Hirsch, M. S. Antiretroviral therapy. Med. Clin. North Am. 1996, 80, 1263-1282.
9. Kashman, Y.; Gustafson, K. R.; Fuller, R. W.; Cardellina, J. H., II; McMahon, J. B.; Currens, M. J.; Buckheit, R. W., Jr.; Hughes; S. H.; Cragg, G. M.; Boyd, M. R. The calanolides, a novel HIV-inhibitory class of courmarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J. Med. Chem. 1992, 35, 2735-2743.
10. Patil, A. D.; Freyer, A. J.; Eggleston, D. S.; Haltiwanger, R. C.; Bean, M. F.; Taylor, P. B.; Caranfa, M. J.; Breen, A. L.; Bartus, H. R.; Johnson, R. K.; Hertxberg, R. P.; Westley, J. W. The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. J. Med. Chem. 1993, 36, 4131-4138.
11. Boyer, P. L.; Currens, M. J.; McMahon, J. B.; Boyd, M. R.; Hughes, S. H. Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 1993, 67, 2412-2420.
12. Hizi, A.; Tal, R.; Shaharabany, M.; Currens, M. J.; Boyd, M. R. Specific inhibition of the reverse transcriptase of human immunodeficiency virus type I and the chimeric enzymes of human immunodeficiency virus type 1 and 2 by nonnucleoside inhibitors. Antimicrob. Agents Chemother. 1993, 37, 1037-1042.
13. Taylor, P. B.; Culp, J. S.; Debouck, C.; Johnson, R. K.; Patil, A. D.; Woolf, D. J.; Brooks, I.; Hertzberg, R. P. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of nonnucleoside inhibitors. J. Biol. Chem. 1994, 269, 6325-6331.
14. Buckheit, R. W.; Fliakas-Boltz, V.; Decker, W. D.; Roberson, J. L.; Stup, T. L.; Pyle, C. A.; White, E. L.; McMahon, J. B.; Currens, M. J.; Boyd, M. R.; Bader, J. P. Comparative anti-HIV evaluation of diverse HIV-1 specific reverse transcriptase inhibitor-resistant. virus isolates demonstrates the existence of distinct phenotypic subgroups. Antiviral Res. 1995, 26, 117-132.
15. Newman, R. A.; Chen, W.; Madden T. HPLC measurement of the novel nonnucleoside anti-HIV agent (+)-dihydrocalanolide A (NSC 678323). J. Liq. Chrom., Relat. Technol. 1997, 20, 651-659.